Tag Archives: HCV

Rayno Biopharmaceutical Stocks Q1 2014 Performance

Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the early February technical levels. Use the two ETFs and FBIOX for re-balancing […]

Comments Off Continue Reading →

Large Cap Biopharmaceutical Stocks Will Lead The Way Up

Large Cap Biopharmaceutical Growth Stocks  With the MoMo days over the next earnings cycle (Q1,Q2 2014) should give us better clarity on winners for 2014.On the last day of March all of these large caps rallied after a severe one week correction from 3/21-28. Watch the technicals this week for bargain hunting, for example, Amgen, […]

Comments Off Continue Reading →

Biotech Stocks Holding At February Lows- Still Up 9% YTD

(See Full Article in Seeking Alpha 3/26) Biopharmaceutical Downdraft 15% From February Highs (IBB$239) Large Cap Biopharmaceutical Stocks Are Core Holdings: ABBV, AMGN, GILD The biotech frenzy of MoMo investing is over so it is time to invest longer term with quality companies. If the sector can hold at February lows, even treading water could […]

Comments Off Continue Reading →

Biotech Bull Market: Key Trend #1 Five Large Cap Biopharmas Plus 2

Two Large Cap Pharmas Are Now Biotech Stocks: Abbvie, Inc. (ABBV) and Bristol -Myers Squibb (BMY) On our last post on the subject we postulated a model that the bull market in biotechnology would ride with the large cap leaders because they are perceived as growth stocks in growing markets : AMGN BIIB CELG GILD […]

Comments Off Continue Reading →

Biopharmaceutical Alerts: ACHN, ARIA, EXEL, SRPT

J.P.Morgan Healthcare Conference Update #3 IBB ($248) New High Today at $249.50 Up 9% YTD–Fidelity Select Biotech (FBIOX) New All time High of $205.85 Up 19% since Dec.18!!! Trading Opportunities-Recovery from Bottom or “Dead Cat” Bounce? Achillion (ACHN $4.18) is up 5% today and 35% for the month. The Company gave an update of their […]

Comments Off Continue Reading →

Biotechnology Sector Closes Month At New Highs Up 5%: BIIB, IBB,VRTX

Biotechnology Stocks Hits New Highs After A Choppy 60 Days Biotechnology stocks eked out small gains today taking the liquid $4.4B  market cap ETF (IBB) to new highs at $225 up 5.58% for the week and 5.94% for the month of November.The $1B market cap ETF (XBI $130.49) also did well making a comeback up […]

Comments Off Continue Reading →